Developing inobrodib (CCS1477), first-in-class p300/CBP inhibitor to treat specific cancers.
Other organizations in the same industry
Latest XRF technology
Alagene is focused on creating the Israeli infrastructure for synthetic biology innovation.
This company is also known as